BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16176799)

  • 1. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism.
    Takikawa O
    Biochem Biophys Res Commun; 2005 Dec; 338(1):12-9. PubMed ID: 16176799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of L-tryptophan in biology: a comparison between tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase.
    Rafice SA; Chauhan N; Efimov I; Basran J; Raven EL
    Biochem Soc Trans; 2009 Apr; 37(Pt 2):408-12. PubMed ID: 19290871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
    Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
    Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis.
    Zhang Y; Kang SA; Mukherjee T; Bale S; Crane BR; Begley TP; Ealick SE
    Biochemistry; 2007 Jan; 46(1):145-55. PubMed ID: 17198384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
    Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
    Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of indoleamine 2,3 dioxygenase activity by H2O2.
    Poljak A; Grant R; Austin CJ; Jamie JF; Willows RD; Takikawa O; Littlejohn TK; Truscott RJ; Walker MJ; Sachdev P; Smythe GA
    Arch Biochem Biophys; 2006 Jun; 450(1):9-19. PubMed ID: 16624246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse and human indoleamine 2,3-dioxygenase display some distinct biochemical and structural properties.
    Austin CJ; Astelbauer F; Kosim-Satyaputra P; Ball HJ; Willows RD; Jamie JF; Hunt NH
    Amino Acids; 2009 Jan; 36(1):99-106. PubMed ID: 18274832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between nitric oxide and indoleamine 2,3-dioxygenase.
    Samelson-Jones BJ; Yeh SR
    Biochemistry; 2006 Jul; 45(28):8527-38. PubMed ID: 16834326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring tryptophan metabolism in chronic immune activation.
    Schröcksnadel K; Wirleitner B; Winkler C; Fuchs D
    Clin Chim Acta; 2006 Feb; 364(1-2):82-90. PubMed ID: 16139256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme-containing enzymes and inhibitors for tryptophan metabolism.
    Yan D; Lin YW; Tan X
    Metallomics; 2017 Sep; 9(9):1230-1240. PubMed ID: 28650043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific interaction of L-tryptophan with CO of CO-bound indoleamine 2,3-dioxygenase identified by resonance Raman spectroscopy.
    Yanagisawa S; Sugimoto H; Shiro Y; Ogura T
    Biochemistry; 2010 Nov; 49(47):10081-8. PubMed ID: 21028817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
    Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human tryptophan dioxygenase: a comparison to indoleamine 2,3-dioxygenase.
    Batabyal D; Yeh SR
    J Am Chem Soc; 2007 Dec; 129(50):15690-701. PubMed ID: 18027945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Density functional theory study on a missing piece in understanding of heme chemistry: the reaction mechanism for indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase.
    Chung LW; Li X; Sugimoto H; Shiro Y; Morokuma K
    J Am Chem Soc; 2008 Sep; 130(37):12299-309. PubMed ID: 18712870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.
    Ball HJ; Sanchez-Perez A; Weiser S; Austin CJ; Astelbauer F; Miu J; McQuillan JA; Stocker R; Jermiin LS; Hunt NH
    Gene; 2007 Jul; 396(1):203-13. PubMed ID: 17499941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
    Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
    Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.
    Ferry G; Ubeaud C; Lambert PH; Bertin S; Cogé F; Chomarat P; Delagrange P; Serkiz B; Bouchet JP; Truscott RJ; Boutin JA
    Biochem J; 2005 May; 388(Pt 1):205-15. PubMed ID: 15636586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.